The role of viral load in the diagnosis, management, and possible prevention of Epstein-Barr virus–associated posttransplant lymphoproliferative disease following solid organ transplantation
Authors:
- 1 September 1999
- journal article
- infection in-transplantation
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 4 (3) , 292-296
Abstract
Recent observations have identified an association between a high viral load of Epstein-Barr virus (EBV) in the peripheral blood and the presence of posttransplant lymphoproliferative disease. Both semiquantitative and quantitative polymerase chain reaction assays have been used to measure the EBV viral load. As a consequence, there has been a growing interest in the use of these assays for diagnosing posttransplant lymphoproliferative disease. A potentially more important development is the use of monitoring of the EBV viral load to prompt preemptive therapy against the development of clinical disease. In addition, serial measurement of the EBV viral load after the diagnosis of EBV/posttransplant lymphoproliferative disease may also provide useful information on the clinical status and response to treatment of symptomatic patients.Keywords
This publication has 14 references indexed in Scilit:
- NATURAL HISTORY OF EPSTEIN-BARR VIRUS LOAD IN PEDIATRIC THORACIC RECIPIENTS WITH POST TRANSPLANT LYMPHOPRO-LIFERATIVE DISORDERS AND OTHER PRIMARY EBV INFECTIONSTransplantation, 1999
- PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1Transplantation, 1998
- SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1Transplantation, 1998
- New strategies in the prevention and management of Epstein-Barr virus infection and posttransplant lymphoproliferative disease following solid organ transplantationCurrent Opinion in Organ Transplantation, 1998
- Recurrent Epstein-Barr virus-associated lesions in organ transplant recipientsHuman Pathology, 1996
- EPSTEIN-BARR VIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES OF PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASETransplantation, 1995
- Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative diseaseBritish Journal of Haematology, 1995
- Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipientsBlood, 1994
- Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative diseaseBlood, 1994
- Quantitative Oropharyngeal Epstein-Barr Virus Shedding in Renal and Cardiac Transplant Recipients: Relationship to Immunosuppressive Therapy, Serologic Responses, and the Risk of Posttransplant Lymphoproliferative DisorderThe Journal of Infectious Diseases, 1992